Drug release from calcium sulfate-based composites.

Current research in orthopedic biomaterials seeks alternatives to autografts. Calcium sulfate is known for its biocompatibility and osteoconductive properties. However, its ability to deliver bioactive agents remains underexplored. Prior studies have shown that calcium sulfate can serve as a scaffold for bone regeneration. Yet, the effects of incorporating various drug types remain unclear. Researchers have not fully characterized how drug incorporation affects mechanical properties. This gap motivated investigations into drug-loaded composites. The need for controlled release systems remains unmet in many clinical applications. Understanding drug release dynamics is crucial for developing effective graft substitutes.

This study aimed to evaluate drug release from calcium sulfate-based composites. The goal was to determine how different drug types and delivery methods affect release profiles. Researchers focused on both small molecules and proteins. They tested direct loading versus encapsulation in poly(β-amino ester) particles. The motivation was to find a reliable method for sustained drug release. Mechanical properties of the composites were also assessed. The study sought to balance therapeutic efficacy with structural integrity. Results could inform the design of improved bone graft substitutes.

The research team prepared calcium sulfate samples with different drug delivery approaches. They used simvastatin as a hydrophobic small molecule and lysozyme as a hydrophilic protein. Some samples incorporated poly(β-amino ester) particles loaded with lysozyme. Compression tests measured the mechanical strength of each composite. Release profiles were monitored over time using analytical techniques. The study compared direct drug loading with encapsulated delivery. Statistical methods evaluated variability in release patterns. The experimental design allowed for a detailed comparison of release mechanisms.

Direct loading of simvastatin provided sustained release over time. Direct loading of lysozyme led to highly variable release profiles. Larger amounts of directly loaded lysozyme caused a 65% initial burst. Encapsulating lysozyme in PBAE particles improved release control. At 1 wt %, PBAE-encapsulated lysozyme showed reduced variability. At 10 wt %, a higher burst was followed by sustained release. Mechanical testing revealed that drug incorporation weakened the composites. PBAE particles reduced strength by 25% at 1 wt % and 80% at 10 wt %. These findings suggest that encapsulation improves drug delivery reliability.

The study demonstrated that calcium sulfate composites can release both small molecules and proteins. Encapsulation in PBAE particles improved lysozyme release consistency. Direct loading of lysozyme resulted in unpredictable release profiles. The researchers observed that drug incorporation significantly reduced mechanical strength. These findings support the potential of calcium sulfate as a drug delivery platform. The study highlights the importance of encapsulation for controlled release. The results suggest that PBAE particles can enhance therapeutic delivery. The authors propose that these materials may find applications in bone graft substitutes.